Dimensional Fund Advisors LP Madrigal Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$203.88 - $312.0 $8,970 - $13,728	44 Added 0.27%	16,345 $3.78 Million
Q1 2023 May 12, 2023	BUY	$231.06 - $307.08 $744,475 - $989,411	3,222 Added 24.63%	16,301 $3.95 Million
Q4 2022 Feb 09, 2023	SELL	$58.39 - $296.54 $1.92 Million - $9.76 Million	-32,916 Reduced 71.56%	13,079 $3.8 Million
Q3 2022 Nov 10, 2022	SELL	$60.57 - $79.51 $7.47 Million - $9.8 Million	-123,299 Reduced 72.83%	45,995 $2.99 Million
Q2 2022 Aug 12, 2022	SELL	$58.04 - $100.2 $2.72 Million - $4.7 Million	-46,903 Reduced 21.69%	169,294 $12.1 Million
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $776,032 - $1.41 Million	13,885 Added 6.86%	216,197 $21.2 Million
Q4 2021 Feb 09, 2022	BUY	$72.34 - $95.09 $2.02 Million - $2.65 Million	27,900 Added 16.0%	202,312 $17.1 Million
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $410,553 - $550,304	5,240 Added 3.1%	174,412 $13.9 Million
Q2 2021 Aug 12, 2021	SELL	$97.2 - $137.59 $324,550 - $459,413	-3,339 Reduced 1.94%	169,172 $16.5 Million
Q1 2021 May 14, 2021	SELL	$108.54 - $125.2 $1.77 Million - $2.04 Million	-16,319 Reduced 8.64%	172,511 $20.2 Million
Q4 2020 Feb 25, 2021	BUY	$110.06 - $133.7 $20.8 Million - $25.2 Million	188,830 New	188,830 $21 Million

336

22.3M

960K

940K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.84B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.